Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. was founded in 1986 and became a member of Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma, SSE stock code 601607) in Jan.2012. Kony is specialized in manufacturing APIs and pharmaceutical intermediates and owns National Medical Products Administration GMP certificate of 8 APIs, some product has CEP certificate. The quality system has been certified by overseas authorities including US FDA, Japan PMDA, Korea KFDA, Brazil ANVISA and Mexican authority. Products have been commercialized in these countries. Our principal products are nucleoside antiviral APIs and intermediates, sartan antihypertensive APIs, proton pump inhibitor APIs and antifungal APIs. Kony is awarded the “high-tech enterprise” and “credit-worthy and contract-abiding unit” in Jiangsu Province. It is also certified by ISO14001, OHSAS18001, provincial safety production standardization secondary enterprises and other related certifications. The company has perfect management system, scientific and reasonable layout, advanced and reliable equipment, flexible and efficient production system, and focuses on safety and environmental protection. It is committed to becoming a high-end pharmaceutical R&D and manufacturing base with product features and technical advantages.